Primary pericardial mesothelioma

October 16, 2007 | Comments Off on Primary pericardial mesothelioma

Lung Cancer. 2007 Oct 11; [Epub ahead of print] [Link] Santos C, Montesinos J, Castañer E, Sole JM, Baga R. Hospital de Sabadell, Corporació Parc Taulí, Institut Universitari, Sabadell-Barcelona, Spain.…

Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy

October 13, 2007 | Comments Off on Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy

International Journal of Radiation Oncology, Biology, Physics. 2007 Dec 1;69(5):1593-9. Epub 2007 Oct 10. [Link] Krayenbuehl J, Oertel S, Davis JB, Ciernik IF. Department of Radiation Oncology, Zurich University Hospital,…

Optimising survival in malignant mesothelioma

October 11, 2007 | Comments Off on Optimising survival in malignant mesothelioma

Lung Cancer. 2007 Aug;57 Suppl 2:S24-9. [Link] Baas P. Department of Thoracic Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. p.baas@nki.nl Abstract The worldwide incidence of…

Role of DNA microarrays in the diagnosis of pleural exudates: a feasibility study

October 11, 2007 | Comments Off on Role of DNA microarrays in the diagnosis of pleural exudates: a feasibility study

Revue des Maladies Respiratoires. 2007 Sep;24(7):859-67. [Link] Greillier L, Roll P, Barlesi F, Robaglia-Schlupp A, Fraticelli A, Cau P, Astoul P. Faculté de Médecine, Université de la Méditerranée, Assistance Publique…

Alpha-Tocopheryl succinate: Toxicity and lack of anti-tumour activity in immuno-competent mice

October 9, 2007 | Comments Off on Alpha-Tocopheryl succinate: Toxicity and lack of anti-tumour activity in immuno-competent mice

Food and Chemical Toxicology . 2007 Aug 29; [Epub ahead of print] [Link] Ireland DJ, Kissick HT, Beilharz MW. Microbiology and Immunology (M502), School of Biomedical, Biomolecular and Chemical Sciences,…

Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): A second line treatment option

October 9, 2007 | Comments Off on Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): A second line treatment option

Lung Cancer. 2007 Oct 3; [Epub ahead of print] [Link] Razak AR, Chatten KJ, Hughes AN. Medical Oncology Department, Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle upon Tyne…

Gene methylation in pleural mesothelioma: Correlations with clinico-pathological features and patient’s follow-up

October 9, 2007 | Comments Off on Gene methylation in pleural mesothelioma: Correlations with clinico-pathological features and patient’s follow-up

Lung Cancer. 2007 Oct 24; [Epub ahead of print] [Link] Destro A, Ceresoli GL, Baryshnikova E, Garassino I, Zucali PA, De Vincenzo F, Bianchi P, Morenghi E, Testori A, Alloisio…

Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed

October 9, 2007 | Comments Off on Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed

Cancer Chemotherapy and Pharmacology. 2007 Oct 6; [Epub ahead of print] [Link] Palumbo C, Battisti S, Carbone D, Albonici L, Alimandi M, Bei R, Modesti A. Department of Experimental Medicine…

Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court

October 6, 2007 | Comments Off on Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court

International Journal of Occupational and Environmental Health. 2007 Jul-Sep;13(3):318-27. [Link] Welch LS. Center to Protect Workers Rights, 8484 Georgia Avenue, Silver Spring, MD 20910, USA. Abstract Manufacturers of asbestos brakes,…

The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions

October 6, 2007 | Comments Off on The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions

Cytopathology. 2007 Oct 4; [Epub ahead of print] [Link] Shield PW, Koivurinne K. Cytology Department, Sullivan Nicolaides Pathology, Taringa, Queensland, Australia Abstract Objective: To determine the value of calretinin and…

Categories